Graduate School of Nursing Dean Joan Vitello, PhD, has been appointed by Gov. Charlie Baker as a member of his special commission to study the incorporation of safe and effective pain treatment and prescribing practices into professional training for future health care providers.
The National Institutes of Health has named School of Medicine student Jacqueline Pires a 2016 Medical Research Scholar. Pires will spend a year in residence conducting mentored independent biomedical research at the NIH’s national headquarters in Bethesda, Md.
UMass Medical School is leading the charge to better train medical and advanced practice nursing students in the prevention and management of opioid abuse, according to an Associated Press story published June 28.
Stephen C. Miller, PhD, associate professor of biochemistry & molecular pharmacology, received a 2016 McKnight Technological Innovations in Neuroscience Award for his work overcoming barriers to imaging in the brain.
Elinor Karlsson, PhD, has enrolled nearly 7,000 dog owners to provide information about their pets, as well as saliva samples, for the Darwin’s Dogs project. Researchers believe the data will help them better understand how the human genome stores and passes on inherited traits.
This year’s Summer Enrichment Program for college undergraduates welcomed 20 high-performing students who learned what it takes to gain entry to medical school.
John Harris MD, PhD, has dedicated his research to better understanding what causes vitiligo, an autoimmune disease that results in the appearance of white spots on the skin, according to an article in the Worcester Telegram & Gazette.
Ann Marshak-Rothstein, PhD, will use the Lupus Insight Prize award to explore the regulatory role of toll-like receptors in an animal model of cutaneous lupus that has strong similarities to the human disease.
Shan Lu, MD, PhD, has received $17.3 million from the National Institute of Allergy and Infectious Diseases to develop and produce an optimized HIV vaccine to be used in Phase II human clinical trials.
UMMS scientists have performed the first CRISPR/Cas9 screen to discover human proteins that Zika virus needs for replication. This work, led by Abraham Brass, MD, PhD, reveals new leads that may be useful for halting Zika, dengue and other emerging viral infections.